查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715363

按疾病、產品類型和最終用戶分類的眼科市場—2025-2030 年全球預測

Ophthalmology Market by Diseases, Product Type, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計 2023 年眼科市場價值將達到 597.8 億美元，2024 年將成長至 637.2 億美元，複合年成長率為 6.62%，到 2030 年將達到 936.9 億美元。

主要市場統計數據
基準年2023年 597.8億美元
預計2024年 637.2億美元
預測年份 2030 936.9億美元
複合年成長率（%） 6.62%

近年來，在科技的快速進步、患者需求的變化和不斷創新的推動下，眼科領域經歷了蓬勃發展。眼科產業的轉型特點是致力於改善患者的治療效果，同時解決一系列與眼睛相關的疾病。這種不斷發展的模式反映了嚴謹的研究、對技術的大量投資以及改進臨床實踐的迭代過程。隨著傳統方法與新診斷工具和治療通訊協定的交叉，該領域正在看到數位健康解決方案的整合不斷增加，從而提高了效率並改善了病人參與。

革命性的手術設備和數位影像技術的引入帶來了模式轉移，不僅提高了診斷的準確性，而且增強了治療性介入的有效性。這些進步以持續的研究和對新興市場需求的深入了解為基礎。醫療保健專業人員、研究人員和技術公司共同努力，為P2P學習和創新創造了肥沃的環境，為患者照護樹立了新的標準。本執行摘要為深入分析奠定了基礎，揭示了推動眼保健未來發展軌蹟的最重要的變革力量和細分動力。

正在重新定義眼科領域的變革

眼科市場正在經歷深刻的變化，重新定義臨床和商業策略。這一變化的前沿是先進診斷和治療技術的整合，這些技術重塑了患者接受護理的方式。行業相關人員正在見證數位解決方案與傳統治療方法的融合，以提高診斷和手術程序的準確性和效率。這些變革性轉變不僅限於技術創新，還包括推動個人化醫療採用的不斷發展的法律規範和報銷格局。

遠端醫療作為遠距離診斷和病患監測的可行、可擴展的解決方案的出現反映了以患者為中心的護理的更廣泛轉變。隨著臨床醫生接受資料分析和人工智慧，該領域的臨床決策能力將會得到改善，這反過來將有助於提高治療成功率。同樣，擴增實境和機器人輔助手術正在透過縮短恢復時間和減少併發症為精準醫療開闢新的途徑。

此外，全球對綜合醫療保健體系的呼籲正在刺激各個研究機構、醫療保健提供者和科技公司之間的合作努力。隨著傳統治療模式日益受到創新方法的挑戰，眼科學界將受益於更便利、更有效率、更有效的眼部疾病整體治療方法。

更深入的細分洞見推動市場動態

眼科市場的複雜性最好透過其多方面的細分來理解。從具體疾病來看，包括老齡化黃斑部病變、白內障、青光眼、發炎性疾病、屈光不良等多種疾病。每種疾病不僅需要量身定做的治療計劃，而且還代表著標靶治療方法的進展指標。

根據產品類型，市場涵蓋藥品、設備、處方眼鏡和鏡片以及軟體解決方案。在醫藥領域，藥品進一步分為治療過敏性結膜炎和發炎的藥物、治療乾眼症的藥物、治療青光眼的藥物和治療視網膜疾病的藥物等。設備是另一個重要類別，分為診斷設備和手術設備。手術器械本身包括人工水晶體和眼科雷射等子區隔，它們在現代外科手術中至關重要。這種細緻的市場區隔使得產業參與者能夠不斷改進其技術和臨床方法，以滿足特定的市場需求。

根據最終用戶評估市場可以揭示進一步的策略見解。醫療服務供應商以及醫院、醫療中心和研究機構在提供眼科護理方面都發揮著至關重要的作用。這種細分凸顯了患者需求、醫療保健基礎設施和創新治療之間的錯綜複雜關係，從而為該領域的有針對性的投資和研究主導的進步提供了清晰的道路。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 眼科疾病盛行率和大眾意識不斷提高
      • 處方眼鏡和隱形眼鏡的普及率不斷提高
      • 擁有完善的醫療基礎設施和不斷增加的藥品核准數量
    • 限制因素
      • 眼部護理費用高昂
    • 機會
      • 眼保健的新研究活動和津貼可用性
      • 眼科技術整合保證高可用性
    • 任務
      • 熟練的眼科醫生數量有限
  • 市場區隔分析
    • 疾病：相當一部分人口患有近視、遠視、散光、老花等屈光不正
    • 產品類型：加大眼科軟體開發投入
    • 最終用戶：世界各地醫療機構正在進行的研究活動
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章 眼科市場（按疾病）

  • 老齡化黃斑部病變
  • 白內障
  • 青光眼
  • 發炎性疾病
  • 屈光不正

第7章眼科市場（依產品類型）

  • 藥物
    • 過敏性結膜炎和發炎藥物
    • 乾眼症藥物
    • 青光眼藥物
    • 視網膜疾病治療
  • 裝置
    • 診斷設備
    • 手術設備
      • 人工水晶體
      • 眼科雷射
  • 處方箋眼鏡和鏡片
  • 軟體

第 8 章眼科市場（按最終用戶分類）

  • 醫療保健服務供應商
  • 醫院
  • 醫療機構
  • 研究組織

第9章美洲眼科市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太眼科市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第 11 章歐洲、中東和非洲的眼科市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023年市場佔有率分析
  • 2023年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • AbbVie Inc.
  • Alcon Inc.
  • Alkeus Pharmaceuticals, Inc.
  • Apotex Inc.
  • Bausch Health Companies Inc.
  • CH Boehringer Sohn AG & Co. KG
  • Carl Zeiss AG
  • ClearSight LLC
  • Duopharma Biotech Berhad
  • Essex Bio-Technology Limited
  • EssilorLuxottica SA
  • Eyenovia, Inc.
  • F. Hoffmann-La Roche AG
  • GenSight Biologics SA
  • Geri-Care Pharmaceuticals Corp.
  • Glaukos Corporation
  • Halma PLC
  • Harrow Health, Inc.
  • Honeywell International Inc.
  • Hoya Corporation
  • Johnson & Johnson Services Inc.
  • Kubota Pharmaceutical Holdings Co., Ltd.
  • Lumenis Be Ltd. by Boston Scientific
  • Nidek Co., Ltd.
  • Novartis AG
  • OCuSOFT, Inc.
  • Oxurion NV
  • Pfizer, Inc.
  • Reichert by Ametek Inc.
  • Santen Pharmaceutical Co., Ltd.
  • SEED Co., Ltd.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • The Cooper Companies, Inc.
  • Topcon Corporation
  • Unimed Pharma, Spols ro
  • Visioncare Optolab Pvt. Ltd.
  • Ziemer Group
Product Code: MRR-4348D129FA96

The Ophthalmology Market was valued at USD 59.78 billion in 2023 and is projected to grow to USD 63.72 billion in 2024, with a CAGR of 6.62%, reaching USD 93.69 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 59.78 billion
Estimated Year [2024] USD 63.72 billion
Forecast Year [2030] USD 93.69 billion
CAGR (%) 6.62%

In recent years the ophthalmology sector has experienced dynamic growth fueled by rapid technological advancements, evolving patient needs, and continuous innovation. The industry's transformation is marked by a commitment to enhancing patient outcomes while addressing a diverse range of eye-related conditions. This evolving landscape reflects rigorous research, substantial investments in technology, and an iterative process of improving clinical practices. As traditional methodologies intersect with novel diagnostic tools and treatment protocols, the sector also sees broader integration of digital health solutions, leading to increased efficiency and improved patient engagement.

The introduction of breakthrough surgical equipment and digital imaging techniques has brought about a paradigm shift that not only increases the accuracy of diagnostics but also amplifies the effectiveness of therapeutic interventions. Such advancements are supported by ongoing research and a deep understanding of emerging market needs. The collaboration among healthcare professionals, researchers, and technology firms has enabled a fertile environment for peer-to-peer learning and innovation, setting new standards in patient care. This executive summary sets the stage for an in-depth analysis that unpacks the transformative forces and segmentation dynamics which are paramount in driving the future trajectory of ophthalmology.

Transformative Shifts Redefining the Ophthalmology Landscape

The ophthalmology market is undergoing significant shifts that are redefining both clinical and commercial strategies. At the forefront of these changes is the integration of advanced diagnostic and therapeutic technologies that have reoriented how patients receive care. Industry stakeholders are witnessing a convergence between digital solutions and traditional treatment modalities, resulting in improved accuracy and efficiency in diagnosis as well as in surgical procedures. These transformative shifts extend beyond technological innovation; they touch upon evolving regulatory frameworks and reimbursement landscapes that encourage the adoption of personalized care.

The emergence of telemedicine as a viable and scalable solution for remote diagnosis and patient monitoring reflects a broader shift towards patient-centric care. As clinicians embrace data analytics and artificial intelligence, the field sees improved clinical decision-making which in turn promotes higher treatment success rates. Similarly, augmented reality and robotic-assisted surgeries are pioneering new pathways in precision medicine by reducing recovery times and minimizing complications.

Furthermore, the global call for integrated healthcare systems is driving collaborative efforts across various research institutes, healthcare providers, and technology companies. As traditional treatment paradigms are increasingly challenged by innovative methods, the industry is set to benefit from a more accessible, efficient, and effective approach to managing a wide range of ophthalmic conditions.

Deep Dive into Segmentation Insights Driving Market Dynamics

The complexity of the ophthalmology market is best understood through its multifaceted segmentation, which offers a clear picture of the diverse factors influencing its growth. When examined by disease, the market encompasses a range of conditions including Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders. Each condition not only demands tailor-made treatment plans but also serves as a benchmark for advancements in targeted therapeutic approaches.

Looking at the product type, the market expands into drugs, equipment, prescription glasses and lenses, and software solutions. Within the realm of pharmaceuticals, drugs are further categorized into segments such as Allergic Conjunctivitis and Inflammation Drugs, Dry Eye Drugs, Glaucoma Drugs, and Retinal Disorder Drugs. Equipment is another critical category that bifurcates into diagnostic devices and surgical devices. Surgical devices themselves constitute a sub-segment including intraocular lenses and ophthalmic lasers which are pivotal in modern surgical interventions. This nuanced breakdown enables industry players to address specific market needs while continually refining their technological and clinical approaches.

Evaluating the market based on end user reveals further strategic insights. Service providers that deliver healthcare along with hospitals, medical institutes, and research organizations each play a vital role in the delivery of eye care. This segmentation underscores the intricate interplay between patient needs, medical infrastructure, and innovative treatments, thereby setting a clear path for targeted investments and research-driven advancements in the field.

Based on Diseases, market is studied across Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders.

Based on Product Type, market is studied across Drugs, Equipment, Prescription Glasses & Lens, and Software. The Drugs is further studied across Allergic Conjunctivitis & Inflammation Drugs, Dry Eye Drugs, Glaucoma Drugs, and Retinal Disorder Drugs. The Equipment is further studied across Diagnostic Devices and Surgical Devices. The Surgical Devices is further studied across Intraocular Lenses and Ophthalmic Lasers.

Based on End User, market is studied across Healthcare Service Providers, Hospitals, Medical Institutes, and Research Organizations.

Regional Insights Shaping Global Ophthalmology Trends

Regional analysis provides crucial visibility into the broad spectrum of growth opportunities and healthcare challenges that shape the ophthalmology market globally. In the Americas, advanced healthcare infrastructure combined with a high level of technological adoption has fostered a robust environment for clinical research and market expansion. Market dynamics in this region are heavily characterized by a strong emphasis on patient-centric innovations and the rapid adoption of digital diagnostic tools.

Across Europe, the Middle East, and Africa, there exists a diverse mix of market maturity levels. Innovative healthcare policies, combined with significant investments in research and development, propel performance improvements and enhanced patient care. Regulatory frameworks in these regions are designed to support both emerging and established players, thereby nurturing an environment of healthy competition and breakthrough innovations.

In the Asia-Pacific region, the growing economies and increasing healthcare awareness have resulted in a surge in demand for sophisticated healthcare services and state of the art diagnostic equipment. Rapid urbanization, coupled with an expanding population, drives the need for scalable and efficient ophthalmic solutions. The interplay of these factors not only broadens market participation but also fuels the development of cost-effective treatment modalities that can be seamlessly integrated into both rural and metropolitan healthcare systems.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Insights Driving Competitive Advantage

Competitive leadership in the ophthalmology market is predominantly steered by companies that have consistently demonstrated innovation and strategic foresight. Leading industry players include AbbVie Inc., Alcon Inc., Alkeus Pharmaceuticals, Inc., Apotex Inc., Bausch Health Companies Inc., C.H. Boehringer Sohn AG & Co. KG, Carl Zeiss AG, ClearSight LLC, Duopharma Biotech Berhad, Essex Bio-Technology Limited, EssilorLuxottica S.A., Eyenovia, Inc., F. Hoffmann-La Roche AG, GenSight Biologics S.A., Geri-Care Pharmaceuticals Corp., Glaukos Corporation, Halma PLC, Harrow Health, Inc., Honeywell International Inc., Hoya Corporation, Johnson & Johnson Services Inc., Kubota Pharmaceutical Holdings Co., Ltd., Lumenis Be Ltd. by Boston Scientific, Nidek Co., Ltd., Novartis AG, OCuSOFT, Inc., Oxurion NV, Pfizer, Inc., Reichert by Ametek Inc., Santen Pharmaceutical Co., Ltd., SEED Co., Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., The Cooper Companies, Inc., Topcon Corporation, Unimed Pharma, Spols r.o., Visioncare Optolab Pvt. Ltd., and Ziemer Group.

These organizations have carved out distinct market positions by investing heavily in research and development and forging strategic alliances that extend their operational capacities both in the domestic and international arenas. Their innovative product portfolios, supported by continuous advancements in technology and impeccable clinical performance records, contribute to heightened industry standards. The synergy between research excellence and commercial strategy has resulted in improved treatment outcomes and a reinforced commitment to patient-centric approaches, thereby driving sustainable market growth.

The report delves into recent significant developments in the Ophthalmology Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Inc., Alkeus Pharmaceuticals, Inc., Apotex Inc., Bausch Health Companies Inc., C.H. Boehringer Sohn AG & Co. KG, Carl Zeiss AG, ClearSight LLC, Duopharma Biotech Berhad, Essex Bio-Technology Limited, EssilorLuxottica S.A., Eyenovia, Inc., F. Hoffmann-La Roche AG, GenSight Biologics S.A., Geri-Care Pharmaceuticals Corp., Glaukos Corporation, Halma PLC, Harrow Health, Inc., Honeywell International Inc., Hoya Corporation, Johnson & Johnson Services Inc., Kubota Pharmaceutical Holdings Co., Ltd., Lumenis Be Ltd. by Boston Scientific, Nidek Co., Ltd., Novartis AG, OCuSOFT, Inc., Oxurion NV, Pfizer, Inc., Reichert by Ametek Inc., Santen Pharmaceutical Co., Ltd., SEED Co., Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., The Cooper Companies, Inc., Topcon Corporation, Unimed Pharma, Spols r.o., Visioncare Optolab Pvt. Ltd., and Ziemer Group. Strategic Recommendations for Industry Leaders

Industry leaders are advised to harness current market trends by focusing on investments in research and development while fostering collaborations that bridge clinical expertise with technological innovation. Embracing digital transformation is essential for improving diagnostic precision and enhancing treatment protocols. A shift towards integrating data analytics and artificial intelligence into clinical decision-making processes can convert raw clinical data into actionable insights, ultimately refining patient care.

Moreover, it is crucial for organizations to actively pursue strategic partnerships with both emerging technology firms and established research institutions. Such collaborative ventures facilitate the exchange of knowledge and promote creations of multi-faceted solutions that address complex ophthalmic conditions. Market leaders should also consider diversifying their product portfolios to include a broader range of drugs and equipment that cater to both high-end and cost-effective treatment options.

Taking proactive steps to monitor evolving regulatory landscapes and patient demographics can further enable leaders to adapt quickly to market changes. Emphasizing sustainable practices while ensuring clinical excellence will not only enhance brand reputation but also ensure long-term viability in an increasingly competitive landscape. By aligning innovation with operational efficiency, industry players stand well-positioned to capitalize on the emerging trends in the ophthalmology market.

Conclusion: Charting the Future for Ophthalmology

The evolving landscape of ophthalmology exemplifies a delicate balance between technological innovation, strategic partnerships, and patient-focused initiatives. Through a detailed examination of market segmentation, regional dynamics, and competitive forces, the findings highlight a clear trajectory pointing towards enhanced diagnostic precision, integrated treatment modalities, and robust patient care. Industry advances in digital health, coupled with sustained investments in research and development, are driving the transformation of care across diverse regions and patient segments.

The convergence of innovative products and clinical excellence is setting new benchmarks in the industry. By capitalizing on technological breakthroughs and tailoring solutions to specific patient needs, stakeholders remain at the forefront of driving change. To realize the full potential of these transformative trends, a collaborative approach that unites clinical expertise with commercial acumen is imperative. This summary encapsulates the fundamental factors propelling the sector forward and reinforces the commitment to achieving higher standards of patient care and business growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of eye disorders and growing awareness among the population
      • 5.1.1.2. Increasing adoption of prescription glasses and lenses
      • 5.1.1.3. Presence of well-equipped healthcare infrastructure and an increasing number of drug approvals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of ophthalmologic treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging research activities of ophthalmology treatments and availability of grants
      • 5.1.3.2. High usage potential owing to the technological integrations in Ophthalmology
    • 5.1.4. Challenges
      • 5.1.4.1. Limited skilled professionals for ophthalmic procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Diseases: Prevalence of refractive errors such as myopia, hyperopia, astigmatism, and presbyopia in a significant portion of the population
    • 5.2.2. Product Type: Increasing investments in software development in ophthalmology
    • 5.2.3. End User: Continuous research activities by medical institutes worldwide
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Ophthalmology Market, by Diseases

  • 6.1. Introduction
  • 6.2. Age-Related Macular Degeneration
  • 6.3. Cataract
  • 6.4. Glaucoma
  • 6.5. Inflammatory Diseases
  • 6.6. Refractive Disorders

7. Ophthalmology Market, by Product Type

  • 7.1. Introduction
  • 7.2. Drugs
    • 7.2.1. Allergic Conjunctivitis & Inflammation Drugs
    • 7.2.2. Dry Eye Drugs
    • 7.2.3. Glaucoma Drugs
    • 7.2.4. Retinal Disorder Drugs
  • 7.3. Equipment
    • 7.3.1. Diagnostic Devices
    • 7.3.2. Surgical Devices
      • 7.3.2.1. Intraocular Lenses
      • 7.3.2.2. Ophthalmic Lasers
  • 7.4. Prescription Glasses & Lens
  • 7.5. Software

8. Ophthalmology Market, by End User

  • 8.1. Introduction
  • 8.2. Healthcare Service Providers
  • 8.3. Hospitals
  • 8.4. Medical Institutes
  • 8.5. Research Organizations

9. Americas Ophthalmology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Ophthalmology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Ophthalmology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Eyenovia and Formosa Pharmaceuticals collaborate to co-develop clobetasol suspension for dry eye disease relief leveraging Optejet technology
    • 12.3.2. Beacon Therapeutics secures USD 170 Million in series B funding to propel ophthalmic gene therapies and drive global expansion
    • 12.3.3. Thea Pharma Inc. introduced new resources to support latanoprost ophthalmic solution patients
    • 12.3.4. BioPhta raises EUR 6.5 million to propel innovative eye disease treatments to clinical trials and expand global reach
    • 12.3.5. Merck's strategic acquisition of EyeBio aims to advance groundbreaking therapies for retinal diseases
    • 12.3.6. Clario and EmSere forge strategic partnership to revolutionize ophthalmic clinical trials with advanced imaging and data integration
    • 12.3.7. Biocon Biologics Limited received U.S. FDA approval for biosimilar aflibercept, enters U.S. ophthalmology market
    • 12.3.8. Topcon and Microsoft join forces to revolutionize ophthalmic diagnostics with AI-powered healthcare platform
    • 12.3.9. A collaboration between Eye2Gene Limited and Heidelberg Engineering, Inc. was announced at ARVO 2024
    • 12.3.10. Nordic Pharma, Inc. gears up for LACRIFILL launch at ASCRS annual meeting
    • 12.3.11. Carl Zeiss Meditec AG strengthens ophthalmology market position with strategic D.O.R.C. acquisition
    • 12.3.12. Viatris leads innovation with the launch of RYZUMVI(TM) 0.75% to revolutionize eye dilation management
    • 12.3.13. Clario and Cleveland Clinic Foundation's Cole Eye Institute formed a strategic partnership for enhanced ophthalmology clinical trials
    • 12.3.14. Roche's Vabysmo launch in India aims to revolutionize retinal disease treatment with affordability and accessibility
    • 12.3.15. Refocus Eye Health is partnering with eight premier practices in New Jersey to enhance specialized eye services
    • 12.3.16. Ikerian AG unveiled a discovery core platform for enhanced ophthalmic data analysis
    • 12.3.17. Cipla joins forces with CSIR-CDRI to innovate ophthalmic antifungal treatments, accelerating R&D and global market reach
  • 12.4. Strategy Analysis & Recommendation
    • 12.4.1. Alcon Inc.
    • 12.4.2. EssilorLuxottica S.A.
    • 12.4.3. AbbVie Inc.
    • 12.4.4. Bausch Health Companies Inc.

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Alcon Inc.
  • 3. Alkeus Pharmaceuticals, Inc.
  • 4. Apotex Inc.
  • 5. Bausch Health Companies Inc.
  • 6. C.H. Boehringer Sohn AG & Co. KG
  • 7. Carl Zeiss AG
  • 8. ClearSight LLC
  • 9. Duopharma Biotech Berhad
  • 10. Essex Bio-Technology Limited
  • 11. EssilorLuxottica S.A.
  • 12. Eyenovia, Inc.
  • 13. F. Hoffmann-La Roche AG
  • 14. GenSight Biologics S.A.
  • 15. Geri-Care Pharmaceuticals Corp.
  • 16. Glaukos Corporation
  • 17. Halma PLC
  • 18. Harrow Health, Inc.
  • 19. Honeywell International Inc.
  • 20. Hoya Corporation
  • 21. Johnson & Johnson Services Inc.
  • 22. Kubota Pharmaceutical Holdings Co., Ltd.
  • 23. Lumenis Be Ltd. by Boston Scientific
  • 24. Nidek Co., Ltd.
  • 25. Novartis AG
  • 26. OCuSOFT, Inc.
  • 27. Oxurion NV
  • 28. Pfizer, Inc.
  • 29. Reichert by Ametek Inc.
  • 30. Santen Pharmaceutical Co., Ltd.
  • 31. SEED Co., Ltd.
  • 32. Sun Pharmaceutical Industries Limited
  • 33. Teva Pharmaceutical Industries Ltd.
  • 34. The Cooper Companies, Inc.
  • 35. Topcon Corporation
  • 36. Unimed Pharma, Spols r.o.
  • 37. Visioncare Optolab Pvt. Ltd.
  • 38. Ziemer Group

LIST OF FIGURES

  • FIGURE 1. OPHTHALMOLOGY MARKET MULTI-CURRENCY
  • FIGURE 2. OPHTHALMOLOGY MARKET MULTI-LANGUAGE
  • FIGURE 3. OPHTHALMOLOGY MARKET RESEARCH PROCESS
  • FIGURE 4. OPHTHALMOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OPHTHALMOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OPHTHALMOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 285. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2023